2؉ chelator, indicating that NO-induced AMPK activation is guanylyl cyclase-mediated and calcium-dependent. Exposure of HUVECs or isolated mice aortas to either calcium ionophore A23187 or bradykinin significantly increased AMPK Thr-172 phosphorylation, which was abolished by N-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthase. Finally, A23187-or bradykinin-enhanced AMPK activation was significantly greater in aortas from wild type mice than those in the aortas of endothelial nitric oxide synthase knock-out mice. Taken together, we conclude that NO might act as an endogenous AMPK activator.The AMP-activated protein kinase (AMPK) 2 is a key enzyme in an important energy-sensing/signaling system by which cells sense and decode changes in energy status. The overall effect of AMPK activation is to switch off ATP-consuming pathways such as lipogenesis or gluconeogenesis, whereas switching on ATP-producing pathways such as fatty acid and glucose oxidation. AMPK is a protein consisting of three subunits designated ␣, , and ␥. The ␣ subunit is the catalytic subunit containing the kinase domain, which transfers a phosphate from ATP to the target protein. The  and ␥ subunits are considered regulatory components (1-3). All three subunits are required for expression of full activity (4).Phosphorylation of Thr-172 on the ␣ subunit by upstream kinases, AMPK kinases, results in AMPK activation. Several upstream kinases have been identified, including a complex of the tumor suppressor protein LKB1 and two accessory subunits, termed STRAD and MO25 (5, 6), and Ca 2ϩ /calmodulindependent protein kinase kinase (CaMKK), especially the CaMKK  isoform (7-9). AMP also allosterically promotes phosphorylation at Thr-172 by LKB1 (10, 11). Any situation that causes an increase in cytoplasmic Ca 2ϩ will create a subsequent demand for ATP because Ca 2ϩ is immediately pumped out of the cytoplasm using ATP-driven pumps in the plasma membrane and endoplasmic reticulum. Activation of AMPK under these circumstances may represent a mechanism to anticipate the demand for ATP created by Ca 2ϩ entry. Nitric oxide (NO) is a small, highly reactive, diffusible free radical that has been implicated in many physiological and pathophysiological processes. NO exerts its effects through many ways including activation of the cGMP/protein kinase G pathway and through S-nitrosylation of proteins (12). There is an emerging body of evidence indicating a relationship between NO and AMPK expression/activity in cells (13). Such a relationship cooperatively promotes glucose and fatty acid oxidation. There is ample evidence showing that AMPK regulates NO production in cells. For example, endothelial nitric oxide synthase (eNOS) is phosphorylated by AMPK at position Ser-*